Daniel Woolson - 30 Aug 2024 Form 4 Insider Report for ICU MEDICAL INC/DE (ICUI)

Reporting relationship: VP, GM-Infusion Capital
Issuer ticker: ICUI
Reported as of: 30 Aug 2024
Net transaction value: -$408,370
SEC form: 4
Accepted by SEC: 30 Aug 2024, 17:26:38 UTC
Prior SEC filing: 15 Mar 2024
Next SEC filing: 06 Dec 2024
Source filing: View source filing
Reporting owner signature: By: Paula Darbyshire, Attorney-in-fact For: Daniel Woolson

Key filing fact

Daniel Woolson filed Form 4 for ICU MEDICAL INC/DE (ICUI) on 30 Aug 2024.

Key facts

This page summarizes Daniel Woolson's Form 4 filing for ICU MEDICAL INC/DE (ICUI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 30 Aug 2024, 17:26.

Change

Previous filing in this sequence was filed on 15 Mar 2024.
Current net transaction value: -$408,370.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ICUI transaction

Common Stock

Sale

Transaction value: $408,370
Shares: -2,502
Change %: -16%
Price: $163.22
Shares after: 13,107
Date: 30 Aug 2024
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The sales price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.00 to $163.825, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full